Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 1
2009 3
2010 8
2011 4
2012 4
2013 1
2015 1
2017 3
2018 6
2019 6
2020 4
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Results by year

Filters applied: . Clear all
Page 1
Plasma 5-miRNA as Biomarkers for Identifying Prostate Cancer Patients.
Saffari M, Modarressi MH, Shirkoohi R, Hassani B, Afsharpad M, Rafiei G, Abroodi G, Yekaninejad MS, Arfaee J, Akrami SM. Saffari M, et al. Among authors: afsharpad m. Iran J Public Health. 2019 Sep;48(9):1743-1745. Iran J Public Health. 2019. PMID: 31700834 Free PMC article. No abstract available.
Expression analysis of a panel of cancer-testis antigens in bladder cancer.
Yazarlou F, Kholghi-Oskooei V, Afsharpad M, Nekoohesh L, Moharrami T, Rad HM, Ghafouri-Fard S, Modarressi MH. Yazarlou F, et al. Among authors: afsharpad m. Per Med. 2018 Nov;15(6):511-520. doi: 10.2217/pme-2018-0049. Epub 2018 Oct 26. Per Med. 2018. PMID: 30362892
Expression profile of miRNAs in urine samples of bladder cancer patients.
Nekoohesh L, Modarressi MH, Mowla SJ, Sadroddiny E, Etemadian M, Afsharpad M, Zolfaghari F, Barzegari M, Saffari M, Oskooei VK, Motevaseli E, Ghafouri-Fard S. Nekoohesh L, et al. Among authors: afsharpad m. Biomark Med. 2018 Dec;12(12):1311-1321. doi: 10.2217/bmm-2018-0190. Epub 2018 Dec 3. Biomark Med. 2018. PMID: 30507304
COVID-19 prognostic modeling using CT radiomic features and machine learning algorithms: Analysis of a multi-institutional dataset of 14,339 patients.
Shiri I, Salimi Y, Pakbin M, Hajianfar G, Avval AH, Sanaat A, Mostafaei S, Akhavanallaf A, Saberi A, Mansouri Z, Askari D, Ghasemian M, Sharifipour E, Sandoughdaran S, Sohrabi A, Sadati E, Livani S, Iranpour P, Kolahi S, Khateri M, Bijari S, Atashzar MR, Shayesteh SP, Khosravi B, Babaei MR, Jenabi E, Hasanian M, Shahhamzeh A, Foroghi Ghomi SY, Mozafari A, Teimouri A, Movaseghi F, Ahmari A, Goharpey N, Bozorgmehr R, Shirzad-Aski H, Mortazavi R, Karimi J, Mortazavi N, Besharat S, Afsharpad M, Abdollahi H, Geramifar P, Radmard AR, Arabi H, Rezaei-Kalantari K, Oveisi M, Rahmim A, Zaidi H. Shiri I, et al. Among authors: afsharpad m. Comput Biol Med. 2022 Jun;145:105467. doi: 10.1016/j.compbiomed.2022.105467. Epub 2022 Mar 29. Comput Biol Med. 2022. PMID: 35378436 Free PMC article.
Overexpression of IGF2BP3 as a Potential Oncogene in Ovarian Clear Cell Carcinoma.
Liu H, Zeng Z, Afsharpad M, Lin C, Wang S, Yang H, Liu S, Kelemen LE, Xu W, Ma W, Xiang Q, Mastriani E, Wang P, Wang J, Liu SL, Johnston RN, Köbel M. Liu H, et al. Among authors: afsharpad m. Front Oncol. 2020 Jan 30;9:1570. doi: 10.3389/fonc.2019.01570. eCollection 2019. Front Oncol. 2020. PMID: 32083017 Free PMC article.
Promising clinical outcomes of nano-curcumin treatment as an adjunct therapy in hospitalized COVID-19 patients: A randomized, double-blinded, placebo-controlled trial.
Sadeghizadeh M, Asadollahi E, Jahangiri B, Yadollahzadeh M, Mohajeri M, Afsharpad M, Najafi F, Rezaie N, Eskandari M, Tavakoli-Ardakani M, Feizabadi F, Masjedi MR. Sadeghizadeh M, et al. Among authors: afsharpad m. Phytother Res. 2023 Aug;37(8):3631-3644. doi: 10.1002/ptr.7844. Epub 2023 Apr 29. Phytother Res. 2023. PMID: 37118944 Clinical Trial.
34 results